ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 117 filers reported holding ENDOCYTE INC in Q2 2018. The put-call ratio across all filers is 1.51 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $786,000 | +9.0% | 44,284 | -15.3% | 0.05% | 0.0% |
Q2 2018 | $721,000 | +43.9% | 52,253 | -5.2% | 0.05% | +24.3% |
Q1 2018 | $501,000 | +173.8% | 55,106 | +29.2% | 0.04% | +146.7% |
Q4 2017 | $183,000 | +18200.0% | 42,658 | +7009.7% | 0.02% | – |
Q3 2017 | $1,000 | -50.0% | 600 | -53.8% | 0.00% | – |
Q2 2017 | $2,000 | -93.5% | 1,300 | -89.3% | 0.00% | -100.0% |
Q1 2017 | $31,000 | -61.2% | 12,200 | -5.4% | 0.00% | -72.7% |
Q1 2015 | $80,000 | +400.0% | 12,900 | +416.0% | 0.01% | +450.0% |
Q4 2014 | $16,000 | -83.8% | 2,500 | -84.7% | 0.00% | -85.7% |
Q3 2014 | $99,000 | -58.4% | 16,326 | -54.9% | 0.01% | -56.2% |
Q2 2014 | $238,000 | -63.7% | 36,200 | +31.4% | 0.03% | -63.2% |
Q1 2014 | $656,000 | +958.1% | 27,545 | +374.9% | 0.09% | +770.0% |
Q4 2013 | $62,000 | – | 5,800 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 3,364,648 | $14,401,000 | 1.20% |
Asymmetry Capital Management, L.P. | 81,484 | $349,000 | 0.47% |
PFM Health Sciences, LP | 3,441,594 | $14,730,000 | 0.35% |
Perceptive Advisors | 1,451,700 | $6,213,000 | 0.21% |
Leisure Capital Management | 28,304 | $121,000 | 0.10% |
Cribstone Capital Management, LLC | 47,349 | $203,000 | 0.10% |
EAM Investors, LLC | 98,034 | $420,000 | 0.08% |
SG3 Management, LLC | 32,500 | $139,000 | 0.05% |
Baker Brothers Advisors | 1,087,323 | $4,654,000 | 0.04% |
Alpine Global Management, LLC | 33,675 | $144,000 | 0.03% |